Anti-Xa assays: What is their role today in antithrombotic therapy?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 31204981.
- Also identified by DOI 10.3949/ccjm.86a.18029.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although some suggest anti-Xa assays should be the preferred method for monitoring intravenous unfractionated heparin therapy, which method is best is unknown owing to the lack of large randomized controlled trials correlating different assays with clinical outcomes. This article provides an overview of heparin monitoring and the pros, cons, and clinical applications of anti-Xa assays.
Medical subject headings
- Antifibrinolytic Agents
- Blood Coagulation Tests
- Drug Monitoring
- Fibrinolytic Agents
- Heparin